Showing 19,681 - 19,700 results of 105,424 for search '(( i de decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.78s Refine Results
  1. 19681

    <i>In vitro</i> characterization of key marker proteins AQP5, ANO1, α-SMA, and CEACAM5 in cultures of the SG by immunofluorescence staining. by Patricia Klaka (4347595)

    Published 2017
    “…<p>(A) Stained secretory coil (sc) and duct (du) sections of native human sweat glands were analyzed in axillary skin tissue (a,d,g,j) compared to <i>in situ</i> glands (dashed lines) with outgrowing cells in 2D cultures (b,e,h,k) and 3D models (c,f,i,l). …”
  2. 19682

    Table_5_Alteration of mRNA 5-Methylcytosine Modification in Neurons After OGD/R and Potential Roles in Cell Stress Response and Apoptosis.XLSX by Huan Jian (10077037)

    Published 2021
    “…<p>Epigenetic modifications play an important role in central nervous system disorders. As a widespread posttranscriptional RNA modification, the role of the m<sup>5</sup>C modification in cerebral ischemia-reperfusion injury (IRI) remains poorly defined. …”
  3. 19683
  4. 19684

    ASO-miR-129-5p down-regulates miR-129-5p and reduces proliferation and migration of Hep-2 cells by MingHua Li (3522803)

    Published 2013
    “…<p>. (A) miR-129-5p expression was significantly decreased after ASO-miR-129-5p transfection compared to GFP transfection (control) or untreated Hep-2 cells (Hep-2 cell) measured by real-time RT-PCR. (* <i>P</i><0.05). …”
  5. 19685

    Image_5_5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.tif by Jiheng Zhang (11953919)

    Published 2022
    “…Consequently, we identified four lncRNAs, including LINC00265, CIRBP-AS1, GDNF-AS1, and ZBTB20-AS4, and established a novel m5C-related lncRNAs signature (m5CrLS) that was effective in predicting prognosis. …”
  6. 19686

    Pathway analysis of genes differentially expressed upon RBM10KD in GLC20 cells. by Julie J. Loiselle (4183750)

    Published 2017
    “…(B) MSigDB Hallmark gene sets enriched at a false discovery rate of below 5% upon RBM10KD in GLC20 cells. …”
  7. 19687

    Extensive DNA End Processing by Exo1 and Sgs1 Inhibits Break-Induced Replication by Vanessa A. Marrero (245931)

    Published 2010
    “…Following cleavage of the plasmid by I-SceI <em>in vivo</em>, <em>de novo</em> telomere synthesis occurs at one end of the vector, and the other end invades at the homologous sequence on chromosome III and initiates replication to the end of the chromosome to generate a stable chromosome fragment (CF). …”
  8. 19688
  9. 19689

    HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial by Anita Y.M. Kwan (11868016)

    Published 2022
    “…</p> <p><b>Conclusions:</b> Dulaglutide 1.5 mg treatment was statistically associated with a long-lasting decrease in HbA1c over 72 months, irrespective of baseline duration of diabetes, microvascular disease, and BMI.…”
  10. 19690
  11. 19691

    Average negative, positive, and net work data for all the walking conditions: Level (0°), downhill (−5°,−10°), and uphill (+5°,+10°) (n = 12). by Nikolaos Papachatzis (12959894)

    Published 2023
    “…During uphill walking, the knee increased the magnitude of net positive work (0° vs. 10°: p = 0.005; +5° vs. +10°: p = 0.012). <b>(D)</b> The hip increased the magnitude of the net negative work when the slope of walking decreased (0° vs. −5°: p = 0.002; −0° vs. −10°: p = 0.002), while uphill walking shifted and increased the hip’s net mechanical behavior (0° vs. +5°: p = 0.002; 0° vs +10°: p = 0.002; +5° vs. +10°: p = 0.002). …”
  12. 19692

    Effects of telomestatin on Topo III signals and Topo III/TRF2/BLM protein levels in MRC5-V1/YFP-Topo III cells. by Nassima Temime-Smaali (260017)

    Published 2009
    “…<p>A, Representative images of untreated MRC5-V1/YFP-Topo III cells and cells treated with 2 µM telomestatin for 48 h; Topo III was detected by fluorescence of YFP-tagged Topo III (green) or by immunofluorescence using D6 antibody (red). …”
  13. 19693
  14. 19694

    Supplementary Material for: Decreasing Trend in Incidence of Late Onset Culture Positive Bloodstream Infections but Not Late Onset Meningitis in Preterm Infants <33 Weeks Gestation... by Zhou Q. (4138852)

    Published 2021
    “…<b><i>Conclusions:</i></b> There was a decreasing trend of late onset CPBSI but not late onset meningitis. …”
  15. 19695
  16. 19696
  17. 19697
  18. 19698
  19. 19699
  20. 19700